Dec 17, 2025 · Sanofi is a research & development-driven, AI-powered healthcare biopharmaceutical company committed to improving lives through innovative medicines & vaccines.

Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi …

Dec 24, 2025 · Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal By Bhanvi Satija and Sriparna Roy December 24, 202512:36 PM PSTUpdated December 24, 2025

Dec 24, 2025 · Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise.

Dec 24, 2025 · The acquisition augments Sanofi's presence in adult immunization by bringing together Dynavax's vaccines with Sanofi's global scale, development capabilities and commercial reach.

2 days ago · Acquisitive Sanofi keeps deals coming, laying out $2.2B for hepatitis vaccine maker Dynavax By Fraiser Kansteiner Dec 29, 2025 10:24am Sanofi Dynavax Technologies mergers and …

2 days ago · The deal adds hepatitis B and early-stage shingles vaccines as Sanofi faces pipeline pressure from tolebrutinib setback.

Dec 24, 2025 · Sanofi will buy U.S. vaccines company Dynavax Technologies for around $2.2 billion (1.9 billion euros), the ‍French drugmaker said on Wednesday.

We would like to show you a description here but the site won’t allow us.